PrimeMD (PRMD) Financial Statements

3 Followers

PrimeMD Financial Overview

PrimeMD's market cap is currently $1.66M. The company's EPS TTM is $0.1556; its P/E ratio is <0.01; PrimeMD is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 21
Income Statement
Total Revenue	$ 10.50M
Gross Profit	$ 10.50M
Operating Income	$ 4.16M
EBITDA	$ 3.43M
Net Income	$ 3.14M
Balance Sheet
Cash & Short-Term Investments	$ 2.59M
Total Assets	$ 15.32M
Total Debt	$ 7.13M
Net Debt	$ 4.54M
Total Liabilities	$ 7.99M
Stockholders' Equity	$ 7.34M
Cash Flow
Free Cash Flow	$ 2.24M
Operating Cash Flow	$ 3.02M
Investing Cash Flow	$ -776.04K
Financing Cash Flow	$ -910.12K

Currency in USD

PrimeMD Earnings and Revenue History

Income Statement >

PrimeMD Debt to Assets

Balance Sheet >

PrimeMD Cash Flow

Cash Flow >

PrimeMD Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >